one prior program of chemotherapy for Innovative breast cancer and through the whole trial, previous publicity to any FGFR inhibitor, main operation or radiotherapy in 4 months before initial dose of review cure and using strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac criteria https://ax-1583611997.blogolenta.com/24916979/getting-my-pf-05221304-to-work